Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents.
about
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α.Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker ratsSynthesis and discovery of novel pyrazole carboxamide derivatives as potential osteogenesis inducers.Description of a bivalent cannabinoid ligand with hypophagic properties.
P2860
Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Antiobesity designed multiple ...... aluation as hypophagic agents.
@en
Antiobesity designed multiple ...... aluation as hypophagic agents.
@nl
type
label
Antiobesity designed multiple ...... aluation as hypophagic agents.
@en
Antiobesity designed multiple ...... aluation as hypophagic agents.
@nl
prefLabel
Antiobesity designed multiple ...... aluation as hypophagic agents.
@en
Antiobesity designed multiple ...... aluation as hypophagic agents.
@nl
P2093
P50
P1476
Antiobesity designed multiple ...... valuation as hypophagic agents
@en
P2093
Fernando Rodríguez de Fonseca
Jose Elguero
Margarita Suardíaz
Mario Alvarado
Pilar Goya
P304
10098-10105
P356
10.1016/J.BMC.2008.10.023
P407
P50
P577
2008-10-14T00:00:00Z